scholarly journals Non-inferiority Trial Investigating the Efficacy of Non-steroidal Anti-inflammatory Drugs and Antimicrobial Treatment of Mild to Moderate Clinical Mastitis in Dairy Cows With Long-lasting Udder Diseases

2021 ◽  
Vol 8 ◽  
Author(s):  
Volker Krömker ◽  
Anne Schmenger ◽  
Doris Klocke ◽  
Ellen Maria Mansion-de Vries ◽  
Nicole Wente ◽  
...  
Keyword(s):  
Antibiotic Therapy ◽  
Dairy Herd ◽  
Clinical Mastitis ◽  
Antimicrobial Treatment ◽  
Reference Treatment ◽  
Treatment Groups ◽  
Streptococcus Uberis ◽  
Cell Counts ◽  
Anti Inflammatory ◽  
Pre Treatment

To reduce ineffective antimicrobial usage in the treatment of non-severe clinical mastitis (CM) in cows with long-lasting udder diseases, non-antibiotic therapy with a non-steroidal anti-inflammatory drug (NSAID) was conducted and evaluated in a non-blinded, positively controlled, non-inferiority trial. Therefore, three-time systemic ketoprofen treatment at intervals of 24 h was evaluated in comparison with the reference treatment of solely antibiotic therapy in a field study on nine free-stall dairy farms located in Northern Germany. Cows with previous CM cases in current lactation and/or with long-lasting high somatic cell counts in preceding dairy herd improvement test days were randomly allocated to one of the two treatment groups in cases of mild to moderate CM. Quarter foremilk samples of the affected quarters were taken for cyto-bacteriological investigation before treatment as well as ~14 and 21 d after termination of therapy. Both treatment groups were compared regarding the bacteriological cure (BC) as the primary outcome. Clinical cure (CC) and no CM relapse within 60 d after the end of treatment (no R60) were chosen as secondary outcomes. The study resulted in the following outcomes: Streptococcus uberis was most frequently identified in microbiological culture from pre-treatment samples, followed by Staphylococcus aureus and Escherichia coli and other coliforms. No significant differences between the NSAID treatment and the reference treatment were detected regarding CC and CM recurrence (no R60). Although the sole ketoprofen therapy resulted in a numerically lower likelihood of BC, there were no significant differences to the reference treatment. Considering the selection criteria in this study, the results indicate that in mild to moderate CM cases exclusive treatment with ketoprofen may constitute an alternative to antimicrobial intramammary therapy, providing an opportunity for reduction of antibiotic usage. However, non-inferiority evaluations were inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a distinct statement on non-inferiority.

Efficacy of standard vs. extended intramammary cefquinome treatment of clinical mastitis in cows with persistent high somatic cell counts

2014 ◽  
Vol 81 (4) ◽  
pp. 424-433 ◽  
Author(s):  
Jantijn M Swinkels ◽  
Volker Krömker ◽  
Theo JGM Lam
Keyword(s):  
Somatic Cell ◽  
Clinical Mastitis ◽  
Least Square ◽  
Controlled Clinical Trial ◽  
Treatment Groups ◽  
Streptococcus Uberis ◽  
Cell Counts ◽  
Significant Difference ◽  
Extended Duration ◽  
Efficacy Criteria

Extended duration of clinical mastitis (CM) treatment has been advocated, although results showing its higher efficacy compared with standard treatment are difficult to compare and seem conflicting. In a non-blinded, positively controlled clinical trial with systematic allocation, the efficacy of a standard, 1·5-d cefquinome treatment (ST), and an extended, 5-d intramammary cefquinome treatment (ET) were evaluated. The latter is frequently performed in cows with persistent high somatic cell count (SCC), expecting a better cure. Therefore, cows with CM immediately preceded by at least two consecutive monthly elevated SCC >200 000 cells/ml, were studied. The primary efficacy criteria were bacteriological cure (BC) and clinical cure (CC), while SCC cure was considered a secondary criterion of cure. Least square means of overall BC were not different after ET (79%, n=206) compared with ST (72%, n=203). ET, as compared with ST, improved BC of CM when caused by streptococci, specifically Streptococcus uberis. At day 1·5, only 13% of quarters showed CC, increasing significantly towards 60% at day 5, and 99% at day 14 and at day 21. No significant difference in CC was present between treatment groups. Overall SCC cure was low (22%) and not significantly different between treatment groups, but significantly higher for cases due to enterobacteriacae compared with staphylococci. In conclusion, ET with cefquinome of CM in cows with a persistent high SCC seems to be only indicated when caused by streptococci, mainly Str. uberis but shows no advantage when no information on bacteriological causes of mastitis is available. In our data, absence of CC directly after ST was not related to eventual BC.

Evaluation of Chlorhexidine as a Premilking Teat Disinfectant for the Prevention of Intramammary Infections During Lactation

1994 ◽  
Vol 57 (7) ◽  
pp. 614-618 ◽  
Author(s):  
S. P. OLIVER ◽  
B. E. GILLESPIE ◽  
M. J. LEWIS ◽  
T. L. INGLE ◽  
H. H. DOWLEN
Keyword(s):  
Mammary Glands ◽  
Clinical Mastitis ◽  
Negative Control ◽  
Coagulase Negative Staphylococcus ◽  
Gram Negative Bacteria ◽  
Intramammary Infections ◽  
Treatment Groups ◽  
Streptococcus Uberis ◽  
Naturally Occurring ◽  
Mastitis Pathogens

A study was conducted for 15 months to evaluate efficacy of a 0.35% chlorhexidine teat dip as a premilking teat disinfectant based on reduction of naturally occurring new intramammary infections. Predipping was compared with a negative control using a split-udder experimental design. All teats were dipped after milking with the same 0.35% chlorhexidine teat dip. Most new major pathogen intramammary infections were caused by Streptococcus species, primarily Streptococcus uberis and Streptococcus equinus and gram-negative bacteria, primarily Escherichia coli. Percentage of quarters newly infected by major mastitis pathogens was 30.6% lower in mammary glands with teats predipped and postdipped in chlorhexidine than in mammary glands with teats postdipped only, and differences between treatment groups approached significance. New infections by coagulase-negative Staphylococcus species were significantly lower in mammary glands with teats predipped and postdipped than in mammary glands with teats postdipped only. When all mastitis pathogens were combined, percentage of quarters newly infected by major and minor mastitis pathogens was significantly lower in the predipped and postdipped group than in the postdipped only group. No statistical differences in incidence of clinical mastitis between treatment groups were observed. No chapping or irritation of teats was observed and no adverse effects were detected using chlorhexidine as a premilking and postmilking teat disinfectant. Results of this study suggest that premilking teat disinfection with chlorhexidine in association with good udder preparation and postmilking teat disinfection can further reduce the occurrence of new intramammary infections during lactation.

Using dairy herd improvement records and clinical mastitis history to identify subclinical mastitis infections at dry-off

2008 ◽  
Vol 75 (2) ◽  
pp. 240-247 ◽  
Author(s):  
Audrey H Torres ◽  
Päivi J Rajala-Schultz ◽  
Fred J DeGraves ◽  
Kent H Hoblet
Keyword(s):  
Dairy Herd ◽  
Cost Effective ◽  
Subclinical Mastitis ◽  
Clinical Mastitis ◽  
Somatic Cell Counts ◽  
Dry Cow Therapy ◽  
Cell Counts ◽  
On Farm ◽  
First 90 Days ◽  
Major Pathogens

Interest in selective dry cow therapy (SDCT) has been increasing owing to concerns over development of antimicrobial resistance. Implementation of SDCT, however, requires a quick and cost-effective on-farm method for identifying cows for treatment and cows that can be left without treatment. The objective of the present study was to evaluate the use of clinical mastitis (CM) history and somatic cell counts (SCC) from monthly Dairy Herd Improvement (DHI) records in identification of infected and uninfected cows at dry-off. A total of 647 Holstein cows were classified as uninfected or infected at dry-off based on CM history and varying number of monthly SCC records (with three different SCC cut-offs). Cows were considered uninfected based on the following criteria: (1) SCC <100 000 cells/ml and no CM during the lactation; (2) SCC <200 000 cells/ml and no CM during the lactation; (3) as criterion two, but additionally a cow was also considered uninfected if it experienced a case of CM during the first 3 months of the lactation and the SCC was <100 000 cells/ml for the rest of the lactation; (4) SCC <300 000 cells/ml and no CM during the lactation; otherwise they were considered infected. Infected and uninfected cows at dry-off were most efficiently identified using three months' SCC records with a threshold of 200 000 cells/ml for cows without CM during the lactation and a threshold of 100 000 cells/ml during the rest of lactation for cows with CM during the first 90 days in milk. Moreover, this criterion also most efficiently identified cows infected with major pathogens only at dry-off. The success of the criteria used for identifying infected and uninfected cows will, however, depend on herd characteristics, such as prevalence of infection and type of pathogens present in the herd.

Selection of cows for treatment at dry-off on organic dairy farms

2016 ◽  
Vol 83 (4) ◽  
pp. 468-475 ◽  
Author(s):  
Klemens Kiesner ◽  
Nicole Wente ◽  
Otto Volling ◽  
Volker Krömker
Keyword(s):  
Geometric Mean ◽  
Selection Criterion ◽  
Dairy Herd ◽  
Clinical Mastitis ◽  
Dry Period ◽  
Organic Farms ◽  
Dry Cow Therapy ◽  
California Mastitis Test ◽  
Cell Counts ◽  
Organic Dairy Farms

Restrictions regarding the use of antibiotics make selective antibiotic dry cow therapy (DCT) mandatory on organic farms in Germany. This requires methods for identifying cows with an intramammary infection (IMI) at dry-off. The aim of this field study was to create a decision scheme for the use of DCT based on cow level factors associated with IMI at dry-off and the probability of both cure and new infection (NI) during the dry period. Data from 250 cows from five organic farms were collected including somatic cell counts (SCC) from Dairy Herd Improvement (DHI) records, California mastitis test (CMT) results at dry-off, clinical mastitis (CM) history, parity and dry-off treatment. IMI at dry-off were most accurate identified using a geometric mean SCC of 100 000 cells/ml as a threshold at either one or three DHI records prior to dry-off. Using a combination of SCC with either CM history, CMT at dry off or parity slightly increased the sensitivity of detection (SE). The probability of cure of the infection over the dry period increased with use of both antibiotic DCT and application of an internal teat sealant (ITS) and decreased when the dry period was longer than 56 d. The risk of NI decreased with the use of ITS and infections with minor pathogens at dry-off. Compared with the selection performed by the farmers during the study period identification of IMI based on the selection criterion with a defined SCC threshold achieved a higher SE.

Associations between somatic cell counts at calving or prior to drying-off and clinical mastitis in the remaining or subsequent lactation

2006 ◽  
Vol 74 (1) ◽  
pp. 66-73 ◽  
Author(s):  
Anne Cathrine Whist ◽  
Olav Østerås
Keyword(s):  
Somatic Cell ◽  
Cox Regression ◽  
Reference Group ◽  
Geometric Mean ◽  
Dairy Herd ◽  
Clinical Mastitis ◽  
Cow Milk ◽  
Somatic Cell Counts ◽  
Cell Counts ◽  
Increased Risk

Data from 350 herds enrolled in the Norwegian Dairy Herd Recording System (NDHRS) were used to investigate the associations between the first two cow-milk somatic cell counts (SCC) test-days’ results after calving or the three last SCC test-days prior to drying off in the first lactation and the hazard ratio (HR) of clinical mastitis (CM) during the remaining first or the subsequent second lactation respectively. Altogether, 9519 first lactations and 6046 second lactations were included. Cox regression analyses adjusted for herd frailty effect were used. In the first lactation, SCC>40000 cells/ml on the first or second test-day was significantly associated with an increased risk of a CM event in the remaining first lactation. HR, compared with 10000 cells/ml, increased from 1·6 (1·4) for SCC of 40000–60000 cells/ml to 6·9 (4·2) for SCC >800000 cells/ml, when using the first (second) SCC test-day in the first lactation. Cows with a geometric mean of the three last SCC test-days between 50000 and 100000 cells/ml and between 401000 and 800000 cells/ml in the first lactation had HR of CM during the second lactation of 1·3 and 2·8 respectively compared with a reference group of 10000–20000 cells/ml. If a CM episode in the first lactation occurred, the HR for having a CM event during the second lactation was 1·5. There was a significant frailty effect which disappeared if the incidence rate of CM at herd level was included in the model.

scholarly journals Development of an improved Streptococcus uberis experimental mastitis challenge model using different doses and strains in lactating dairy cows

2015 ◽  
Vol 82 (4) ◽  
pp. 470-477 ◽  
Author(s):  
Manouchehr Khazandi ◽  
Patricia Eats ◽  
Darren Trott ◽  
Esmaeil Ebrahimie ◽  
Jeanette Perry ◽  
...  
Keyword(s):  
Success Rate ◽  
Bovine Mastitis ◽  
Clinical Signs ◽  
Clinical Mastitis ◽  
Clinical Findings ◽  
Infection Model ◽  
Treatment Groups ◽  
Streptococcus Uberis ◽  
Reliable Model ◽  
High Doses

Developing a reliable mastitis challenge infection model is required to test new intramammary antimicrobial preparations, other novel bovine mastitis treatments, and study mastitis pathogenesis. Three treatment groups of Holstein Friesian cows in active lactation were administered two doses (104 and 106 cfu/quarter) on a single occasion with one of the three Streptococcus uberis strains (BFR6019, MFF1283 and SA002) suspended in 5 ml of sterile PBS, administered via intramammary inoculation immediately after milking. All quarters that were challenged with S. uberis strains MLF1283 and BFR6019 showed clinical signs of mastitis on day 1 and 2 after the challenge. Strain SA002 had a lower rate of inducing clinical mastitis which was detected later than day 3 after the challenge. We successfully developed a rapid and reliable model for inducing experimental S. uberis mastitis with 100% success rate in cows in active lactation. On the basis of the correlation results between strains, RAPD fingerprinting results, clinical findings, and a 100% success rate of mastitis induction for low and high doses S. uberis strains MLF1283 and BFR6019, strain virulence seems to be a more important effect than challenge dose in induction of clinical mastitis following experimental challenge.

Milk L-lactate concentration is increased during mastitis

2004 ◽  
Vol 71 (2) ◽  
pp. 175-181 ◽  
Author(s):  
Stephen R Davis ◽  
Vicki C Farr ◽  
Colin G Prosser ◽  
Gina D Nicholas ◽  
Sally-Anne Turner ◽  
...  
Keyword(s):  
Clinical Symptoms ◽  
Post Partum ◽  
Lactate Concentration ◽  
Fold Increase ◽  
Subclinical Mastitis ◽  
Clinical Mastitis ◽  
Streptococcus Uberis ◽  
Cell Counts ◽  
Commercial Farms ◽  
The Impact

A study was undertaken in cattle to evaluate changes in milk L-lactate in relation to mastitis. A healthy, rear quarter of the udder of each of ten cows in mid-lactation was infused with 1000 colony-forming units (cfu) of Streptococcus uberis following an afternoon milking. Foremilk samples were taken at each milking from control and treated quarters and antibiotic treatment was applied following the onset of clinical mastitis or after 72 h. One cow did not become infected. Six quarters showed clinical symptoms of mastitis within 24–40 h and this was associated with a more than 30-fold increase in milk L-lactate (to 3·3 mM) and an increase in somatic cell count (SCC) from 4·5×103 to 1×107 cells/ml. Three cows were subclinical, with cell counts ranging from 1·5×106 to 1×107 cells/ml. In these animals, milk lactate ranged from 0·7 to 1·5 mM in the infected quarters up to 40 h post-infection, compared with less than 0·1 mM in control quarters. Milk was examined from 137 cows in mid-lactation which were known to have mastitis. Foremilk samples were taken aseptically from control and infected quarters of cows on commercial farms. Mean milk L-lactate concentrations and SCC were 0·14±0·02 mM and 1·85±0·3×105 cells/ml, respectively, in control (bacteriologically negative) samples. However, L-lactate concentrations exceeded 2·5 mM in the presence of some types of infection, the level of the lactate response being closely related to the impact of the infection on SCC. L-Lactate concentrations were relatively elevated in milk samples taken post partum, declining from 0·8 to 0·14 mM over the first few days of lactation. In conclusion, milk L-lactate has potential as an indicator of clinical and subclinical mastitis in dairy cows.

scholarly journals Molecular Detection and Sensitivity to Antibiotics and Bacteriocins of Pathogens Isolated from Bovine Mastitis in Family Dairy Herds of Central Mexico

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Ma. Fabiola León-Galván ◽  
José E. Barboza-Corona ◽  
A. Arianna Lechuga-Arana ◽  
Mauricio Valencia-Posadas ◽  
Daniel D. Aguayo ◽  
...  
Keyword(s):  
Bacillus Thuringiensis ◽  
Bovine Mastitis ◽  
Dairy Herd ◽  
Subclinical Mastitis ◽  
Herd Size ◽  
Clinical Mastitis ◽  
Dairy Herds ◽  
Coagulase Negative Staphylococci ◽  
California Mastitis Test ◽  
Streptococcus Uberis

Thirty-two farms (n=535cows) located in the state of Guanajuato, Mexico, were sampled. Pathogens from bovine subclinical mastitis (SCM) and clinical mastitis (CLM) were identified by 16S rDNA and the sensitivity to both antibiotics and bacteriocins ofBacillus thuringiensiswas tested. Forty-six milk samples were selected for their positive California Mastitis Test (CMT) (≥3) and any abnormality in the udder or milk. The frequency of SCM and CLM was 39.1% and 9.3%, respectively. Averages for test day milk yield (MY), lactation number (LN), herd size (HS), and number of days in milk (DM) were 20.6 kg, 2.8 lactations, 16.7 animals, and 164.1 days, respectively. MY was dependent on dairy herd (DH), LN, HS, and DMP<0.01, and correlations between udder quarters from the CMT were around 0.49P<0.01. Coagulase-negative staphylococci were mainly identified, as well asStaphylococcus aureus,Streptococcus uberis,Brevibacterium stationis,B. conglomeratum, andStaphylococcus agnetis. Bacterial isolates were resistant to penicillin, clindamycin, ampicillin, and cefotaxime. Bacteriocins synthesized byBacillus thuringiensisinhibited the growth of multiantibiotic resistance bacteria such asS. agnetis,S. equorum,Streptococcus uberis,Brevibacterium stationis, andBrachybacterium conglomeratum, but they were not active againstS. sciuri, a microorganism that showed an 84% resistance to antibiotics tested in this study.

scholarly journals Comparison of systemic and intramammary dry cow treatments

2013 ◽  
pp. 3259-3264 ◽  
Author(s):  
G. Andres Contreras B ◽  
Walter M. Guterbock ◽  
Juan Muñoz R ◽  
Phillip M. Sears
Keyword(s):  
Dairy Herd ◽  
Lactation Period ◽  
Cure Rate ◽  
Gram Positive ◽  
Intramammary Infections ◽  
Treatment Groups ◽  
Somatic Cell Counts ◽  
Milk Samples ◽  
Cell Counts ◽  
Dairy Herd Improvement Association

ABSTRACTObjective. To compare four different dry cow treatments (DCT) and establish their effectiveness in reducing intramammary infections (IIM). Materials and methods. DCTs included systemic tylosin (12g) alone or accompanied by cefapirine intramammary infusions and or an internal teat sealant. A total number of 278 cows at the end of lactation period were randomly assigned to one of 4 dry cow treatment groups: CESE Group (n=89), intramammary cephapirin and teat sealant. TYCESE Group (n=84), intramammary cephapirin, tylosin 12 g intramuscular and teat sealant. TYSE Group (n=86), 12 g intramuscular tylosin and teat sealant; TY Group (n=76) 12 g intramuscular tylosin only. Milk samples for culture were collected at dry-off and 1 and 2 weeks after calving. Somatic cell counts (SCC) were taken from Dairy Herd Improvement Association (DHI) tests at dry-off, and the first two test days after calving. Results. Bacteria cure rate for Gram-positive intramammary infections (IMI) for TYCESE group was 93.6%, CESE group 78.9%, TYSE group 88.2%, and TY group 78.1%. All four groups showed a decrease in the SCC upon the first and second test after calving. Conclusions. The use of systemic tylosin in combination with intramammary antibiotics increased DCT effectiveness improving the Gram-positive cure rate IMI. Furthermore, systemic tylosin alone plus teat sealant is as effective as cephapirin plus teat sealant when used as DCT.

scholarly journals Khasiat Ekstrak Buah Markisa Kuning (P. Edulis Sims) sebagai Antiinflamasi Dilihat dari Jumlah Monosit pada Tikus Wistar Jantan (Rattus norvegicus)

2018 ◽  
Vol 15 (2) ◽  
pp. 34
Author(s):  
Hardhika Oktarianda Fachri ◽  
Winny Adriatmoko ◽  
Pudji Astuti
Keyword(s):  
Passion Fruit ◽  
Fruit Extract ◽  
Passiflora Edulis ◽  
Treatment Groups ◽  
Cell Counts ◽  
Male Wistar Rats ◽  
Monocyte Cell ◽  
Anti Inflammatory ◽  
And Control ◽  
Yellow Passion Fruit

Yellow passion fruit contains carotenoids and polyphenols which are believed to be used as alternative treatments. Yellow passion fruit is thought to provide anti- inflammatory effects. The objective was to determine the efficacy of giving yellow passion fruit extract to inflammation seen from monocyte counts. This study used 12 male Wistar rats were divided into normal groups, treatment groups, and control groups. In the treatment group, yellow passion fruit extract was given 100% concentration. On the 1st, 3rd, and 7th day the blood edge of the rat was taken and the number of monocyte cell counts was performed. Based on the results of One Way Anova analysis there were differences in the number of monocyte cells between all groups. Yellow passion fruit extract (Passiflora edulis Sims) is efficacious as anti-inflammatory due to a decrease in the number of monocytes.

Sign in / Sign up

Export Citation Format

Share Document